Floatz logo

19 assets in Digestive System Carcinoma

Therapeutic assets addressing Digestive System Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Cyclophosphamide
Digestive System Carcinoma
National Cancer Institute (NCI)P2B (60)
Irinotecan
Digestive System Carcinoma
National Cancer Institute (NCI)P1/2CCC (54)
Fludarabine
Digestive System Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Kras Tcr-Transduced Pbl
Digestive System Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Tipiracil
Digestive System Carcinoma
Emory UniversityP1/2CCC (48)
Trifluridine
Digestive System Carcinoma
Emory UniversityP1/2CCC (48)
Elimusertib
Digestive System Carcinoma
National Cancer Institute (NCI)P1CC (43)
Fluorouracilum
Digestive System Carcinoma
National Cancer Institute (NCI)P1CC (43)
[18f]f-resca-g5
Digestive System Carcinoma
RenJi HospitalN/AD (30)
[18f]f-resca-rb14
Digestive System Carcinoma
RenJi HospitalN/AD (30)
[18F]F-RESCA-RND20
Digestive System Carcinoma
RenJi HospitalN/AD (30)
[18F]F-RESCA-T4
Digestive System Carcinoma
RenJi HospitalN/AD (30)
[18f]f-resca-wwh347
Digestive System Carcinoma
RenJi HospitalN/AD (30)
[68Ga]Ga-DOTA-H2D3
Digestive System Carcinoma
RenJi HospitalN/AD (30)
[68ga]ga-nota-g5
Digestive System Carcinoma
RenJi HospitalN/AD (30)
[68ga]ga-nota-rnd20
Digestive System Carcinoma
RenJi HospitalN/AD (30)
[68ga]ga-nota-t4
Digestive System Carcinoma
RenJi HospitalN/AD (30)
[68Ga]Ga-NOTA-WWH347
Digestive System Carcinoma
RenJi HospitalN/AD (30)
Mvf-Her-2 (266-296)
Digestive System Carcinoma
Pravin T.P KaumayaP1NR ()